Department of Molecular Genetics, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran.
Mol Genet Metab. 2011 Jan;102(1):29-32. doi: 10.1016/j.ymgme.2010.09.001. Epub 2010 Sep 16.
Identification of molecular basis of phenylketonuria (PKU) in Iran has been accomplished through the analysis of 248 unrelated chromosomes from 124 Iranian classic PKU subjects. Phenylalanine hydroxylase (PAH) gene mutations were analyzed through a combined approach in which p.S67P, p.R252W, p.R261Q, p.R261X, p.L333F, IVS10-11G>A, IVS11+1G>C, p.L364del, p.R408Q and p.R408W mutations were first screened by PCR of PAH gene exons 3, 7, 10, 11 and 12, followed by digestion with the appropriate digestion enzymes. Subsequently SSCP analysis for exons 2, 6, 7 and 11 of the PAH gene and finally, sequencing of 13 PAH gene exons have been used to study uncharacterized PKU chromosomes. 26 different mutations were found. The predominant mutation in this population sample was IVS10-11G>A, with a frequency of 24.6%. Nine mutations (IVS10-11G>A, p.R261Q, p.P281L, IVS11+1G>C, p.K363>NFS, p.R243X, IVS2+5G>C, p.R261X and p.R252W) represent almost 84% of all PKU chromosomes studied. IVS10-11G>A mutation is the major PKU-causing mutation throughout the Mediterranean region. The finding of the high prevalence of this mutation in Iranian population is consistent with the historical and geographical links between Iranian and Mediterranean populations.
已通过对 124 名伊朗经典苯丙酮尿症(PKU)患者的 248 条无关染色体进行分析,确定了伊朗 PKU 的分子基础。通过联合分析方法分析了苯丙氨酸羟化酶(PAH)基因突变,首先对 PAH 基因外显子 3、7、10、11 和 12 进行 PCR 筛选 p.S67P、p.R252W、p.R261Q、p.R261X、p.L333F、IVS10-11G>A、IVS11+1G>C、p.L364del、p.R408Q 和 p.R408W 突变,然后用相应的酶进行消化。随后对 PAH 基因外显子 2、6、7 和 11 进行 SSCP 分析,最后对 13 个 PAH 基因外显子进行测序,用于研究未表征的 PKU 染色体。发现了 26 种不同的突变。该人群样本中主要的突变是 IVS10-11G>A,频率为 24.6%。9 种突变(IVS10-11G>A、p.R261Q、p.P281L、IVS11+1G>C、p.K363>NFS、p.R243X、IVS2+5G>C、p.R261X 和 p.R252W)代表了研究的所有 PKU 染色体的近 84%。IVS10-11G>A 突变是整个地中海地区导致 PKU 的主要突变。在伊朗人群中发现这种突变的高流行率与伊朗和地中海人群之间的历史和地理联系是一致的。